Stay updated on XEN801 Topical Gel Clinical Trial
Sign up to get notified when there's something new on the XEN801 Topical Gel Clinical Trial page.

Latest updates to the XEN801 Topical Gel Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal regarding a Phase 1/2 study for XPF-005, including details about the study's design, participant criteria, and safety assessments. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference31%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4, indicating a revision in the content.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to XEN801 Topical Gel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN801 Topical Gel Clinical Trial page.